Intellia Therapeutics Announces Proposed Public Offering of Common Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/3/2026
- Wall St ends higher as stocks reclaim some shine
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Snowflake soars 20% on earnings beat and raised guidance
- Oil settles 1% higher, as US-Iran strikes threaten supplies
- Could Apple’s foldable iPhone be a $14B opportunity? Morgan Stanley weighs in
Intellia Therapeutics (NTLA) PT Raised to $42 at Jefferies
November 1, 2017 7:48 AM EDTJefferies raised its price target on Intellia Therapeutics (NASDAQ: NTLA) to $42.00 (from $36.00) while maintaining a Buy rating.
... MoreIntellia Therapeutics (NTLA) PT Raised to $36 at Wedbush
November 1, 2017 7:26 AM EDTWedbush raised its price target on Intellia Therapeutics (NASDAQ: NTLA) to $36.00 (from $29.00) while maintaining a Outperform rating.
... More